TITLE

Neurogenic neuroprotection: clinical perspectives

AUTHOR(S)
Mandel, Mauricio; Fonoff, Erich Talamoni; Bor-Seng-Shu, Edson; Teixeira, Manoel Jacobsen; Chadi, Gerson
PUB. DATE
October 2012
SOURCE
Functional Neurology;Oct-Dec2012, Vol. 27 Issue 4, p207
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
No abstract available.
ACCESSION #
87629279

 

Related Articles

  • The Sixth Sense. Morris, Richard J.; Sveum, Richard J. // Environmental Health Perspectives;Feb1994, Vol. 102 Issue 2, p1 

    Presents a letter to the editor on neurogenic inflammation, published in the February 1994 issue of the journal "Environmental Health Perspectives."

  • Neuroprotektion durch Edelgase: Neue Entwicklungen und Erkenntnisse. Fahlenkamp, A. V.; Rossaint, R.; Coburn, M. // Anaesthesist;Nov2015, Vol. 64 Issue 11, p855 

    Noble gases are chemically inert elements, some of which exert biological activity. Experimental neuroprotection in particular has been widely shown for xenon, argon and helium. The underlying mechanisms of action are not yet fully understood. Besides an interference with neuronal ion-gated...

  • Neurodegenerative diseases: Novel route to neuroprotection. Burridge, Samia // Nature Reviews Drug Discovery;Dec2012, Vol. 11 Issue 12, p906 

    The article discusses on molecules with broad pro-neurogenic or neuroprotective properties which could be used for therapeutic applications in neurodegenerative diseases. It was found that P7C3 an aminopropyl cabazole with neurogenic properties showed therapeutic effects in both mouse and worm...

  • Practical importance of neuroprotection in Parkinson's disease. Riederer, P.; Gille, G.; Müller, T.; Przuntek, H.; Reichmann, H.; Riess, O.; Schwartz, A.; Schwarz, J.; Vogt, T. // Journal of Neurology;Dec2002 Supplement 3, Vol. 249, piii53 

    Consensus could be reached that there is overwhelming evidence of preclinical neuroprotection. However, the evidence of neuroprotection/neurorescue under clinical conditions is limited. Lessons from clinical trials designed to show neuroprotection (selegiline, amantadine, dopamine agonists)...

  • New Books Received.  // Kidney International;Jul1974, Vol. 6 Issue 1, p65 

    The article presents information on the book "The Urologic Clinics of North America," vol. 1, "Symposium on Neurogenic Bladder."

  • What is Neuropathic Pain? Gilmer, Tim // New Mobility;Jan2015, p14 

    The article explains the clinical characteristics of neuropathic or neurogenic pain, its causes, and the medicine that can relieve the pain.

  • Nörojenik pulmoner ödem tanısı ile takip edilen olgularımız. Sarı, Mehmet Yusuf; Yıldızdaş, Rıza Dinçer; Yükselmiş, Ufuk; Horoz, Özden Ögür // Turkish Archives of Pediatrics;2015, Vol. 50 Issue 4, p241 

    Neurogenic pulmonary edema is a clinical situation which developes as a result of central nervous system injury. It is rare in the childhood. Neurogenic pulmonary edema is a clinical diagnosis. Although the pathogenesis is not elucidated well, there is increase in pulmonary interstitial and...

  • A novel natural product inspired scaffold with robust neurotrophic, neurogenic and neuroprotective action. Chakravarty, Sumana; Maitra, Swati; Reddy, R Gajendra; Das, Tapatee; Jhelum, Priya; Kootar, Scherazad; Rajan, Wenson D.; Samanta, Anumita; Samineni, Ramesh; Pabbaraja, Srihari; Kernie, Steven G.; Mehta, Goverdhan; Kumar, Arvind // Scientific Reports;9/25/2015, p14134 

    In search for drugs to treat neuropsychiatric disorders wherein neurotrophic and neurogenic properties are affected, two neurotrophically active small molecules specially crafted following natural product leads based on 2-oxa-spiro[5.5]-undecane scaffold, have been thoroughly evaluated for their...

  • ORAL SESSION: NEUROPROTECTION AND NEUROPLASTICITY.  // Romanian Journal of Neurology;2008 Supplement 1, Vol. 7, pS19 

    The article presents abstracts on neuroprotection and neuroplasticity, including "How to improve endogenous neuroprotection?" by L. Vescei, "The conceptual limits of neuroprotective clinical trials in Parkinson's disease: Is there a solution?" by M. Gerlach and "Mechanisms of cell death and...

  • Measuring Neuroprotection in Clinical Practice. Viswanathan, Ananth // Ophthalmology Times;5/1/2007 Neuroprotection in Glaucom, Vol. 32, p7 

    The article provides information on the development of neuroprotection measurement in clinical practice. Measure human neuroprotection is fundamentally linked to the clinical measurement to the progression of glaucoma. However, identification of the progression's surrogate markers remains a...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics